Modules
Sequoia Clinical Partners, PLLC
Customer 9506
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ | Vendor | 1a0917814c75bc72340fadb513367c7efb88b72884b81f1f819506850529dc04
- Assigned Reps
- Raymond Sutter
- Website
- —
- Active Opportunity Count
- 14
- Published Count
- 7
- Revenue Base
- 23783.59
- Known GPBase
- 4960.06
- Analyzer Platforms
- Beckman Access / DxI | MicroGenics | Horiba
- Product Groups
- Beckman Access | Bio-Rad | Parts Group | MicroGenics | Horiba
- Recommended Contact
- Piper Halbrook (Operations Manager) OM
- Backup Contact
- Kyle Marrow (Primary) | Research & Development | kyle.marrow@sequoiaclinicalpartnerspllc.com | (401) 441-1114
- Last Meaningful Activity
- 2026-05-06
- Customer Memory
- Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is MicroGenics. Verified item fact: storage requirement Fridge. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Horiba. Verified item fact: storage requirement Fridge. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement N/A. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement Fridge. Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-51814804149304927da6cad598af1db70a01552667b3746aaaf86726379a08bb | Customer 9506 | Candidate CAND-8cfd273aa666779a3528c51047734884157637fc372a3f6a08c7241c4d6bfbff | Customer 9506 | Candidate CAND-3849e92df23203d8a15135731649f1c4e457ef0f282c60e0264597941ecc5f08 | Customer 9506 | Order 51910 | Item 13539 | Candidate CAND-003fdc14379009c89f8cc88a8eed26cb4948e570c5c150a880491e59138ef67f | Customer 9506 | Order 53085 | Item 14722 | Candidate CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | Customer 9506 | Order 52723 | Item 11553 | Candidate CAND-78492e3dc059a4cbb863e7eb733c974932bb26c08087edec3739136254d5909b | Customer 9506 | Quote 30041 | Item 17133 | Candidate CAND-d149b8dee67796bb5f7c93c91d0c1e54469996b81309eccffd4a94fcfac633a7 | Customer 9506 | Item 13143 | Candidate CAND-b385ade3647104c901f6183894a76d56c8d219c221b6cf9a5fd74b46f604896c | Customer 9506 | Order 52398 | Item 17063
Opportunities (21)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-51814804149304927da6cad598af1db70a01552667b3746aaaf86726379a08bb | OPP-a423420a165ff0c0abc869590ab7e246fbc5551fc36a983cc99b822b2a61007b | SER-598bbcae822dd4f273c8b8d5bdd363ec7a7eb43d3cdac9a5aa1666a7c0816418 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | Norwood | MA | Northeast | End-User Laboratory | High | — | Bio-Rad | — | — | — | — | Product Family Purchasing Loss; 5 independent signals; trailing 90-day revenue $3217.79 versus $10768.14; trailing 180-day revenue $13985.93 versus $24800.28; -5 days beyond expected account order date. | 3775.18 | 7550.35 | 11325.53 | 1356.45 | 2712.9 | 4069.35 | 87.59 | High | False | True | — | CALL | Candidate CAND-51814804149304927da6cad598af1db70a01552667b3746aaaf86726379a08bb | Customer 9506 |
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8cfd273aa666779a3528c51047734884157637fc372a3f6a08c7241c4d6bfbff | OPP-ce9dd30192b5388a60e161ac6fe39e6a350b29eb7cb20f05503b48f0402f51ce | SER-844e76fa0d3f647814538fe193dd59611a6ea1c6e97baf752e1a132aa4de6ab2 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | — | Parts Group | — | — | — | — | Product Family Purchasing Loss; 5 independent signals; trailing 90-day revenue $3822.19 versus $9135.32; trailing 180-day revenue $12957.51 versus $23346.55; 7 days beyond expected account order date. | 2656.57 | 5313.13 | 7969.7 | 674.86 | 1349.72 | 2024.58 | 80.33 | High | False | True | — | CALL | Candidate CAND-8cfd273aa666779a3528c51047734884157637fc372a3f6a08c7241c4d6bfbff | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3849e92df23203d8a15135731649f1c4e457ef0f282c60e0264597941ecc5f08 | OPP-e791aba0a427b7f7c8b916cd7998e3a9ae540661c0ce168c30e79e9843cfeea3 | SER-83b3005746405c669c3f1fc1afc98cf1394e69347654ec0883079df324009d76 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | MicroGenics | MicroGenics | T-0373589 | Kit VANCO TGT QMS, 22, 22mL | — | 51910 | 5 completed purchases over 231 days; median interval 50.0 days; expected reorder 2026-07-05; High Risk by 36 days. | 599.25 | 799 | 998.75 | 179.33 | 239.1 | 298.88 | 68.84 | High | False | False | — | CALL | Candidate CAND-3849e92df23203d8a15135731649f1c4e457ef0f282c60e0264597941ecc5f08 | Customer 9506 | Order 51910 | Item 13539 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b385ade3647104c901f6183894a76d56c8d219c221b6cf9a5fd74b46f604896c | OPP-57941519219ed4b0465fe3d9f73170335703cdcb0a727099d9146a7d98ede589 | SER-eae1a9874b216b5be3c17c3c788174d950ccbf10ba96816483862d1df361e7d6 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | Horiba | Horiba | 5390015750 | Lipid Control Set, 6 x 3mL | — | 52398 | 8 completed purchases over 358 days; median interval 41.0 days; expected reorder 2026-08-03; Overdue by 7 days. | 208.42 | 277.89 | 347.36 | 28.27 | 37.69 | 47.11 | 63.82 | Medium | False | False | — | CALL | Candidate CAND-b385ade3647104c901f6183894a76d56c8d219c221b6cf9a5fd74b46f604896c | Customer 9506 | Order 52398 | Item 17063 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-003fdc14379009c89f8cc88a8eed26cb4948e570c5c150a880491e59138ef67f | OPP-0f7a9ebd945570961c90c7b78ed3d7a0d7fab078df543af3cbcf31d0dc23297d | SER-d547bb1f81d916bcbb8feae8cd4c26adca2a20cad79cd71d6e24e80c9d6309af | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | Horiba | Horiba | 5390013106 | Direct Hemoglobin A1c Reagent - AU | — | 53085 | 15 completed purchases over 399 days; median interval 25.5 days; expected reorder 2026-08-18; Due Soon in 8 days. | 260.08 | 346.77 | 433.47 | 48.77 | 65.02 | 81.28 | 63.8 | High | False | False | — | CALL | Candidate CAND-003fdc14379009c89f8cc88a8eed26cb4948e570c5c150a880491e59138ef67f | Customer 9506 | Order 53085 | Item 14722 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | OPP-a21e7721efae8e327c02ed55669676f4bc25d47fcfa0a11879956924bc2ebf70 | SER-aaf9756c8fe0d6b588b9942b2c4aeecc898cd5d276443ee19a9297c609a71be2 | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | Norwood | MA | Northeast | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A16792 | A16792 Beckman Access Wash Buffer, Pkg/4 bottles, 1.9 L/bottle | — | 51659 | 7 completed purchases over 764 days; median interval 64.0 days; expected reorder 2026-06-06; High Risk by 65 days. | 114 | 152 | 190 | 57.06 | 76.08 | 95.1 | 62.34 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | OPP-f6c330c1bcf265b6565eaede3d6d25154b770e3a4eb26a79d32bba35490f4efe | SER-1bdc7a03e4dc801b535523808f3e7d7b7b364ec674ef0442d7cef162b1403fcc | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | Norwood | MA | Northeast | End-User Laboratory | High | MicroGenics | MicroGenics | T-10016154 | Thermo Kit EtG Rgt DRI CJF | — | 52723 | 11 completed purchases over 407 days; median interval 47.5 days; expected reorder 2026-08-18; Due Soon in 8 days. | 316.67 | 422.23 | 527.79 | -1056 | -844.8 | -633.6 | 61.42 | Needs Validation | False | False | — | MANAGER_REVIEW | Candidate CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | Customer 9506 | Order 52723 | Item 11553 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | OPP-df4aa375c50be6bcf2d75c098db96f32a0bf9ef3f40e9c2ae93b9f32565ef9f7 | SER-7e7cfe189b68a9072cc00308b1ba65a542e77e29961f4a0d30767077e01a68f0 | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | Horiba | Horiba | 5390013099 | Calcium (CPC) Reagent - AU | — | 52722 | 8 completed purchases over 378 days; median interval 51.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | 123.9 | 165.2 | 206.5 | 27.72 | 36.97 | 46.21 | 60.01 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | OPP-68a6b356e8b1e91f7d93e0ee5039dc0956f0ffa49a33f6fd972a920b1b9e08df | SER-19fe3fe8c57c498a2c017656a2d740610b1d9277c7bd6e3408b66aad6e805869 | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | MicroGenics | MicroGenics | T-1797 | Thermo Kit Creat-Detect 500mL | — | 52722 | 8 completed purchases over 365 days; median interval 57.0 days; expected reorder 2026-08-31; Due Soon in 21 days. | 236.25 | 315 | 393.75 | 47.25 | 63 | 78.75 | 59.18 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | OPP-c3e7fd5a65fc4382836b136dc8a3306644ae2bc3b5a26692fe2833bec0c20e84 | SER-3208d44d9962f9a6226644f1a450f3fcdc28fd445551a77074ee154f73b60407 | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | Horiba | Horiba | 5390013098 | Carbon Dioxide Reagent - AU | — | 53138 | 13 completed purchases over 404 days; median interval 32.5 days; expected reorder 2026-09-03; Due Soon in 24 days. | 115.44 | 153.92 | 192.4 | 20.22 | 26.96 | 33.7 | 57.5 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | OPP-e979ddff463cdbcccd1566745026835521279ff2bb0082e1063303eb5008fbda | SER-e3e1a66ea801d0ce70136a45d71c8ad2c209fa9911f612df0bd82fb1d595faae | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | MicroGenics | MicroGenics | T-10009958 | Thermo Kit Gen Oxidant | — | 51204 | 3 completed purchases over 182 days; median interval 91.0 days; expected reorder 2026-06-28; Overdue by 43 days. | 186.19 | 248.25 | 310.31 | 62.06 | 82.75 | 103.44 | 55.78 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | Customer 9506 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | OPP-31eac9393c4310f087145e1f4445d02de35ba0179705d4518a05773e8964057d | SER-d4c567c636550c25961a5d336646ff9ebf27041946c66c9ddbc5ff38cb4c03ba | Needs Validation | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | Norwood | MA | Northeast | End-User Laboratory | High | MicroGenics | MicroGenics | T-100054 | Thermo Kit pH-Detect 500mL | — | 51910 | 4 completed purchases over 304 days; median interval 87.0 days; expected reorder 2026-08-14; Due Soon in 4 days. | 198.37 | 264.49 | 330.61 | 40.12 | 53.49 | 66.86 | 52.41 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | Customer 9506 |
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78492e3dc059a4cbb863e7eb733c974932bb26c08087edec3739136254d5909b | OPP-5141fed715b92c1bccaebd73f44ff632d064240fa4df7c45399002366249fdfc | SER-23659bfe4f4a30b66a7d2282331a5d5b45d17159f003308bee4daaae44b87843 | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | — | Norwood | MA | Northeast | End-User Laboratory | High | — | Parts Group | Misc Equipment New | Pentra 80XL New | 30041 | — | Stale Open Quote on quote 30041; quote age 138 days; last modified 133 days ago; quoted value $43342.25; converted line value $0.00; unconverted line value $43342.25. | 4334.23 | 8668.45 | 13002.68 | — | — | — | 73.13 | Medium | False | True | — | RESEND_QUOTE | Candidate CAND-78492e3dc059a4cbb863e7eb733c974932bb26c08087edec3739136254d5909b | Customer 9506 | Quote 30041 | Item 17133 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d149b8dee67796bb5f7c93c91d0c1e54469996b81309eccffd4a94fcfac633a7 | OPP-58791fe30cbe59fbebe0a9753aaa2520b7c79b6f419e77cf37a69e26a149822b | SER-cf891317bacef97bca042700bff2c1b207246650bcabd1c30cf59438a822f2be | Published | **** | **** | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | Norwood | MA | Northeast | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | B84493 | B84493 - Access Sensitive Estradiol Reagent, 100 Determinations, 2 x 50 tests | — | — | Verified by Description for Beckman Access / DxI; item purchased by 14 of 40 comparable active sites (35.0%); peer median annual revenue $828.00. | 414 | 828 | 1242 | 277.81 | 555.63 | 833.44 | 66.96 | Medium | False | False | — | CONFIRM_ANALYZER | Candidate CAND-d149b8dee67796bb5f7c93c91d0c1e54469996b81309eccffd4a94fcfac633a7 | Customer 9506 | Item 13143 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | OPP-a21e7721efae8e327c02ed55669676f4bc25d47fcfa0a11879956924bc2ebf70 | SER-aaf9756c8fe0d6b588b9942b2c4aeecc898cd5d276443ee19a9297c609a71be2 | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | HQ | — | MA | — | — | — | Beckman Access / DxI | — | — | — | — | — | 7 completed purchases over 764 days; median interval 64.0 days; expected reorder 2026-06-06; High Risk by 65 days. | — | 152 | — | — | 76.08 | — | 62.34 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | Customer 9506 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | OPP-f6c330c1bcf265b6565eaede3d6d25154b770e3a4eb26a79d32bba35490f4efe | SER-1bdc7a03e4dc801b535523808f3e7d7b7b364ec674ef0442d7cef162b1403fcc | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | HQ | — | MA | — | — | — | MicroGenics | — | — | — | — | — | 11 completed purchases over 407 days; median interval 47.5 days; expected reorder 2026-08-18; Due Soon in 8 days. | — | 422.23 | — | — | — | — | 61.42 | Needs Validation | — | — | — | MANAGER_REVIEW | Candidate CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | Customer 9506 | Order 52723 | Item 11553 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | OPP-df4aa375c50be6bcf2d75c098db96f32a0bf9ef3f40e9c2ae93b9f32565ef9f7 | SER-7e7cfe189b68a9072cc00308b1ba65a542e77e29961f4a0d30767077e01a68f0 | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | Vendor | — | MA | — | — | — | Horiba | — | — | — | — | — | 8 completed purchases over 378 days; median interval 51.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | — | 165.2 | — | — | 36.97 | — | 60.01 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | Customer 9506 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | OPP-68a6b356e8b1e91f7d93e0ee5039dc0956f0ffa49a33f6fd972a920b1b9e08df | SER-19fe3fe8c57c498a2c017656a2d740610b1d9277c7bd6e3408b66aad6e805869 | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | Vendor | — | MA | — | — | — | MicroGenics | — | — | — | — | — | 8 completed purchases over 365 days; median interval 57.0 days; expected reorder 2026-08-31; Due Soon in 21 days. | — | 315 | — | — | 63 | — | 59.18 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | Customer 9506 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | OPP-c3e7fd5a65fc4382836b136dc8a3306644ae2bc3b5a26692fe2833bec0c20e84 | SER-3208d44d9962f9a6226644f1a450f3fcdc28fd445551a77074ee154f73b60407 | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | Vendor | — | MA | — | — | — | Horiba | — | — | — | — | — | 13 completed purchases over 404 days; median interval 32.5 days; expected reorder 2026-09-03; Due Soon in 24 days. | — | 153.92 | — | — | 26.96 | — | 57.5 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | Customer 9506 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | OPP-e979ddff463cdbcccd1566745026835521279ff2bb0082e1063303eb5008fbda | SER-e3e1a66ea801d0ce70136a45d71c8ad2c209fa9911f612df0bd82fb1d595faae | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | Vendor | — | MA | — | — | — | MicroGenics | — | — | — | — | — | 3 completed purchases over 182 days; median interval 91.0 days; expected reorder 2026-06-28; Overdue by 43 days. | — | 248.25 | — | — | 82.75 | — | 55.78 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | Customer 9506 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | OPP-31eac9393c4310f087145e1f4445d02de35ba0179705d4518a05773e8964057d | SER-d4c567c636550c25961a5d336646ff9ebf27041946c66c9ddbc5ff38cb4c03ba | — | **** | — | — | Sequoia Clinical Partners, PLLC | 9506 | Vendor | — | MA | — | — | — | MicroGenics | — | — | — | — | — | 4 completed purchases over 304 days; median interval 87.0 days; expected reorder 2026-08-14; Due Soon in 4 days. | — | 264.49 | — | — | 53.49 | — | 52.41 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | Customer 9506 |